- Home
- SSKN vs NERV Comparison
SSKN vs NERV Comparison
Compare SSKN & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- NERV
- Stock Information
- Founded
- SSKN 1989
- NERV 2007
- Country
- SSKN United States
- NERV United States
- Employees
- SSKN N/A
- NERV N/A
- Industry
- SSKN Medical/Dental Instruments
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- NERV Health Care
- Exchange
- SSKN Nasdaq
- NERV Nasdaq
- Market Cap
- SSKN 10.6M
- NERV 10.7M
- IPO Year
- SSKN 2005
- NERV 2014
- Fundamental
- Price
- SSKN $2.70
- NERV $1.56
- Analyst Decision
- SSKN Strong Buy
- NERV Hold
- Analyst Count
- SSKN 1
- NERV 1
- Target Price
- SSKN $6.00
- NERV $5.00
- AVG Volume (30 Days)
- SSKN 4.0K
- NERV 12.8K
- Earning Date
- SSKN 03-27-2025
- NERV 04-30-2025
- Dividend Yield
- SSKN N/A
- NERV N/A
- EPS Growth
- SSKN N/A
- NERV N/A
- EPS
- SSKN N/A
- NERV 0.19
- Revenue
- SSKN $33,562,000.00
- NERV N/A
- Revenue This Year
- SSKN $0.79
- NERV N/A
- Revenue Next Year
- SSKN $8.17
- NERV N/A
- P/E Ratio
- SSKN N/A
- NERV $8.68
- Revenue Growth
- SSKN 0.61
- NERV N/A
- 52 Week Low
- SSKN $2.51
- NERV $1.42
- 52 Week High
- SSKN $5.90
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- SSKN 50.18
- NERV 44.40
- Support Level
- SSKN $2.53
- NERV $1.54
- Resistance Level
- SSKN $2.72
- NERV $1.89
- Average True Range (ATR)
- SSKN 0.13
- NERV 0.07
- MACD
- SSKN 0.01
- NERV 0.03
- Stochastic Oscillator
- SSKN 63.33
- NERV 44.00
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.